目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Cancer Type
1.2.2. Test Type
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research End-use
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Cancer Type and test type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Skin Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements
3.2.1.2. Integration of artificial intelligence
3.2.1.3. Patient preference for non-invasive diagnostics
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Diagnostic Imaging
3.3. Skin Cancer Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Skin Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis
4.1. Global Skin Cancer Diagnostics Market: Cancer Type Dashboard
4.2. Global Skin Cancer Diagnostics Market: Cancer Type Movement Analysis
4.3. Global Skin Cancer Diagnostics Market by Cancer Type, Revenue
4.4. Melanoma
4.4.1. Melanoma market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Non-Melanoma
4.5.1. Non-Melanoma market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Skin Cancer Diagnostics Market: Test Type Estimates & Trend Analysis
5.1. Global Skin Cancer Diagnostics Market: Test Type Dashboard
5.2. Global Skin Cancer Diagnostics Market: Test Type Movement Analysis
5.3. Global Skin Cancer Diagnostics Market by Test Type, Revenue
5.4. Dermatoscopy
5.4.1. Dermatoscopy market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Skin Biopsy
5.5.1. Skin Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Lymph node biopsy
5.6.1. Lymph node biopsy market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Imaging Tests
5.7.1. Imaging Tests market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Others
5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Skin Cancer Diagnostics Market: Test Type Estimates & Trend Analysis
6.1. Global Skin Cancer Diagnostics Market: End-use Dashboard
6.2. Global Skin Cancer Diagnostics Market: End-use Movement Analysis
6.3. Global Skin Cancer Diagnostics Market by End-use, Revenue
6.4. Hospital and Clinics
6.4.1. Hospital and Clinics market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Laboratories
6.5.1. Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others Analysis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Skin Cancer Diagnostics Market: Regional Estimates & Trend Analysis by Cancer Type, Test Type ad End-use
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Mexico
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Castle Bioscience
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. DermTech
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. bioMérieux , Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. FOUNDATION MEDICINE, INC.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. DermaSensor, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. F . Hoffmann-La Roche Ltd
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. NeoGenomics Laboratories
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Quest Diagnostics Incorporated
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. SkylineDx
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Abbott
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America skin cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 North America skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 4 North America skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 5 North America skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 7 U.S. skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 8 U.S. skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 10 Canada skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 11 Canada skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe skin cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 13 Europe skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 14 Europe skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 15 Europe skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 16 Germany skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 17 Germany skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 18 Germany skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 20 UK skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 21 UK skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 22 France skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 23 France skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 24 France skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 26 Italy skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 27 Italy skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 29 Spain skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 30 Spain skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 32 Denmark skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 33 Denmark skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 34 Sweden skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 35 Sweden skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 36 Sweden skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 38 Norway skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 39 Norway skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific skin cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 42 Asia Pacific skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 44 China skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 45 China skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 46 China skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 48 Japan skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 49 Japan skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 50 India skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 51 India skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 52 India skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 53 South Korea skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 54 South Korea skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 55 South Korea skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 56 Australia skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 57 Australia skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 58 Australia skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 60 Thailand skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 61 Thailand skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America skin cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 64 Latin America skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 65 Latin America skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 66 Brazil skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 67 Brazil skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 68 Brazil skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 70 Mexico skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 71 Mexico skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 73 Argentina skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 74 Argentina skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 75 MEA skin cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 76 MEA skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 77 MEA skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 78 MEA skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 80 South Africa skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 81 South Africa skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 86 UAE skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 87 UAE skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait skin cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 89 Kuwait skin cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 90 Kuwait skin cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Skin cancer diagnostics market: market outlook
Fig. 14 Skin cancer diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Skin cancer diagnostics market driver impact
Fig. 18 Skin cancer diagnostics market restraint impact
Fig. 19 Skin cancer diagnostics market: Cancer Type movement analysis
Fig. 20 Skin cancer diagnostics market: Cancer Type outlook and key takeaways
Fig. 21 Melanoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Non-Melanoma estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Skin cancer diagnostics market: Test Type movement analysis
Fig. 24 Skin cancer diagnostics market: Test Type outlook and key takeaways
Fig. 25 Dermatoscopy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Skin biopsy estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Lymph node biopsy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Imaging tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Others estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Skin cancer diagnostics market: End-use movement analysis
Fig. 31 Skin cancer diagnostics market: End-use outlook and key takeaways
Fig. 32 Hospital and clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Laboratories estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Others estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Global skin cancer diagnostics market: Regional movement analysis
Fig. 36 Global skin cancer diagnostics market: Regional outlook and key takeaways
Fig. 37 Global skin cancer diagnostics market share and leading players
Fig. 38 North America, by country
Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 U.S. key country dynamics
Fig. 41 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Canada key country dynamics
Fig. 43 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 UK key country dynamics
Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Germany key country dynamics
Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 France key country dynamics
Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Italy key country dynamics
Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Spain key country dynamics
Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Denmark key country dynamics
Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Sweden key country dynamics
Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Norway key country dynamics
Fig. 60 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 China key country dynamics
Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Japan key country dynamics
Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 India key country dynamics
Fig. 67 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Thailand key country dynamics
Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 South Korea key country dynamics
Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Australia key country dynamics
Fig. 73 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Brazil key country dynamics
Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Mexico key country dynamics
Fig. 78 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Argentina key country dynamics
Fig. 80 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 South Africa key country dynamics
Fig. 83 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Saudi Arabia key country dynamics
Fig. 85 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 UAE key country dynamics
Fig. 87 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Kuwait key country dynamics
Fig. 89 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Market share of key market players - Skin cancer diagnostics market